Nyxoah SA Ordinary Shares NYXH 深 沪
等待开盘 10-22 09:30:00 美东时间
5.73
-0.140
-2.39%
华盛通- 最 高5.9375
- 今 开5.83
- 成交量 2.60万股
- 最 低 5.705
- 昨 收 5.87
- 总市值 2.15亿
- 52周最高 11.87
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 4.345
- 委 比 -64.36%
- 总股本 3744.11万
- 历史最高 37.00
- 量 比 0.77
- 振 幅 3.96%
- 历史最低 4.00
- 每 手 1
- 风险率 3.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多First US Patients Implanted With Nyxoah's CE-Marked Genio System Signal Strong Demand For Breakthrough Sleep Apnea Therapy
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio SystemEarly Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorizations, and Widespread Payor Coverage
10-06 13:59
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
Nyxoah announced the first U.S. commercial patients implanted with its Genio® system following FDA approval, marking a significant milestone in treating Obstructive Sleep Apnea (OSA). CEO Olivier Taelman highlighted strong physician demand, successful pre-authorization, and widespread payer coverage. Dr. Andrew T. Huang, the first surgeon to implant Genio commercially in the U.S., praised the system's effectiveness and ease of use. Nyxoah is trac...
10-06 05:00
Nyxoah Enters Underwriting Agreement for Public Offering
The latest announcement is out from Nyxoah ( ($NYXH) ). On September 18, 2025, ...
09-24 04:58
Nyxoah Announces Continued Expansion Of Commercial Footprint In Middle East, Following First Genio Implant In Abu Dhabi In September 2025
Nyxoah Provides an Update on Expanded Middle East PresenceNew Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025Mont-Saint-Guibert, Belgium – September 23, 2025,
09-24 04:12
Nyxoah Provides an Update on Expanded Middle East Presence
Nyxoah expands its Middle East presence with new centers in Dubai, Kuwait, and Abu Dhabi, following the first successful Genio® implant in the region in September 2025. The company aims to increase access to its patient-centric treatment for Obstructive Sleep Apnea (OSA) and improve patient outcomes.
09-23 20:10
Kepler Capital Remains a Buy on Nyxoah (NYXH)
In a report released on September 16, Christophe dombu from Kepler Capital main...
09-18 09:45
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems Over Sleep Apnea Device Technology
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) and Nyxoah,
09-16 04:11
Nyxoah Announces Change in Voting Rights Stake by Cochlear
Nyxoah ( ($NYXH) ) just unveiled an announcement. On September 5, 2025, Nyxoah ...
09-09 04:27
Nyxoah Announces Transparency Notification on Shareholding Changes
The latest update is out from Nyxoah ( ($NYXH) ). Nyxoah SA has announced a tra...
09-06 10:02
Nyxoah Announces Upcoming Investor Events
Nyxoah, a medical technology company developing solutions for Obstructive Sleep Apnea (OSA), announced its participation in several investor events in September 2025, including the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, and Baird's Global Healthcare Conference. The Company will host live webcasts of these events and be available for one-on-one meetings with investors.
09-02 20:30
